Forbearance Agreements in the Biotechnology Industry
14 Contracts & Agreements
- Allarity Therapeutics, Inc. (2 contracts)
- Alliqua BioMedical, Inc. (4)
- Arsanis, Inc. (1)
- GT Biopharma, Inc. (4)
- TG THERAPEUTICS, INC. (1)
- Trovagene, Inc. (1)
- U.S. Stem Cell, Inc. (1)
- First Amendment to Forbearance Agreement and Waiver (Allarity Therapeutics, Inc., Filed With SEC on June 10, 2022)
- Forbearance Agreement and Waiver (Allarity Therapeutics, Inc., Filed With SEC on May 6, 2022)
- Form of Second Amendment and Extension of Standstill and Forbearance Agreement (GT Biopharma, Inc., Filed With SEC on February 2, 2021)
- STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on June 23, 2020)
- Forbearance Agreement, dated August 8, 2018, by and between the Registrant and Silicon Valley Bank (Arsanis, Inc., Filed With SEC on August 13, 2018)
- SECOND FORBEARANCE AGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on August 10, 2017)
- AMENDMENT NO.2 TO FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on May 1, 2017)
- AMENDMENT NO.1 TO FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on March 13, 2017)
- FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on January 30, 2017)
- LIMITED WAIVER AND FORBEARANCE AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 7, 2014)
- STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on May 21, 2012)
- WAIVERAND FORBEARANCE AGREEMENT (TG THERAPEUTICS, INC., Filed With SEC on February 14, 2011)
- STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on October 9, 2009)
- FORBEARANCE AGREEMENT (Trovagene, Inc., Filed With SEC on February 4, 2009)
